1. 1110. AZD7442 (Tixagevimab/Cilgavimab) Demonstrates Potent In Vitro Activity Against SARS-CoV-2 Spike Variants Identified in Circulation and in Prophylaxis Clinical Studies. (15th December 2022) Authors: Tuffy, Kevin M; Abram, Michael E; Roe, Tiffany L; Ahani, Bahar; Brady, Tyler; Schuko, Nicolette; Clarke, Lori; Caceres, Carolina; Kenny, Tara; Takahashi, Virginia; Zhang, Tianhui; Tabor, David E; Kijak, Gustavo H; Kelly, Elizabeth J; Streicher, Katie Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1160. Treatment-Emergent Viral Variants in the Phase 3 TACKLE Trial Investigating Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for the Treatment of Mild to Moderate COVID-19 in Adults. (15th December 2022) Authors: Kijak, Gustavo H; Ahani, Bahar; Arbetter, Douglas; Brady, Tyler; Chuecos, Fernando; Gopalakrishnan, Vancheswaran; Roe, Tiffany L; Schuko, Nicolette; Richard Hobbs, F D; Padilla, Francisco; Kelly, Elizabeth J; Montgomery, Hugh; Streicher, Katie Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination. (15th December 2022) Authors: Sobieszczyk, Magdalena E; Falsey, Ann R; Luetkemeyer, Anne F; Paulsen, Grant C; Riddler, Sharon A; Robb, Merlin L; Rolle, Charlotte-Paige M; Sha, Beverly E; Tong, Tina; Ahani, Bahar; Aksyuk, Anastasia A; Bansal, Himanshu; Green, Justin A; Jepson, Brett; Maaske, Jill; Shoemaker, Kathryn; Sproule, ... Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India. (December 2021) Authors: Kulkarni, Prasad S; Padmapriyadarsini, Chandrasekaran; Vekemans, Johan; Bavdekar, Ashish; Gupta, Madhu; Kulkarni, Praveen; Garg, B S; Gogtay, Nithya J; Tambe, Muralidhar; Lalwani, Sanjay; Singh, Kiranjit; Munshi, Renuka; Meshram, Sushant; Selvavinayagam, T S; Pandey, Krishna; Bhimarasetty, Devi M... Journal: EClinicalMedicine Issue: Volume 42(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019. (22nd November 2022) Authors: Levin, Myron J; Ustianowski, Andrew; Thomas, Steven; Templeton, Alison; Yuan, Yuan; Seegobin, Seth; Houlihan, Catherine F; Menendez-Perez, Ibrahim; Pollett, Simon; Arends, Rosalinda H; Beavon, Rohini; Dey, Kanika; Garbes, Pedro; Kelly, Elizabeth J; Koh, Gavin C K W; Ivanov, Stefan; Near, Karen A;... Journal: Clinical infectious diseases Issue: Volume 76:Number 7(2023) Page Start: 1247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Issue 10267 (19th December 2020) Authors: Ramasamy, Maheshi N; Minassian, Angela M; Ewer, Katie J; Flaxman, Amy L; Folegatti, Pedro M; Owens, Daniel R; Voysey, Merryn; Aley, Parvinder K; Angus, Brian; Babbage, Gavin; Belij-Rammerstorfer, Sandra; Berry, Lisa; Bibi, Sagida; Bittaye, Mustapha; Cathie, Katrina; Chappell, Harry; Charlton, Sue... Journal: Lancet Issue: Volume 396:Issue 10267(2020) Page Start: 1979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination. Issue 4 (26th April 2022) Authors: Wilkins, Deidre; Aksyuk, Anastasia A; Ruzin, Alexey; Tuffy, Kevin M; Green, Tina; Greway, Rebecca; Fikes, Brittany; Bonhomme, Cyrille J; Esser, Mark T; Kelly, Elizabeth J Journal: Clinical & translational immunology Issue: Volume 11:Issue 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗